August 19, 2022 UMD Home FabLab AIMLab


Hydrogels

Hydrogels

 

The Fischell Department of Bioengineering research group is the first to use molecular imprinting to capture viruses. The patented technology shows promise in treating the H5N1 virus, the cause of the avian flu. It may also lead to new treatments for diabetes and more reliable vaccines. The concept shows great promise for a number of health care advances.

Called a "virus sponge," Professor Kofinas uses an inexpensive hydrogel to make an imprint of the target molecule and trap it as blood flows through the hydrogel. Kofinas sees a variety of cost-effective uses for the technology. He envisions machines similar to dialysis being used to remove viral infections from blood. Hepatitis and HIV could also be filtered from the blood.

Beyond viruses, Kofinas sees molecular imprinting being used in drugs and food additives to make life easier for diabetics by removing glucose. He also suggests using the technology in masks or protective clothing to prevent exposure to harmful biological agents.



May 8, 2007


«Previous Story  

 

 

Current Headlines

2022 Sony Research Award Program Invitation

Attoh-Okine Named UMD CEE Chair

Rethinking the Architecture of Solid-State Batteries: ION Closes $30M Investment Round

Liangbing Hu Named Finalist for 2022 Blavatnik National Awards for Young Scientists

Electrified Heating Towards Green Methane Conversion and Ammonia Synthesis

In the News: Leatherbacks Combat Robotics Team on ABC7

UMD Dedicates IDEA Factory

Engineering at Maryland magazine celebrates the power of philanthropy, impact on students

UMD Inventions of the Year Tackle Grand Challenges

JC Zhao Receives Humboldt Research Award

 

Colleges A. James Clark School of Engineering
The College of Computer, Mathematical, and Natural Sciences

Communicate Join Email List
Contact Us
Follow us on TwitterTwitter logo

Links Privacy Policy
Sitemap
RSS

Copyright The University of Maryland University of Maryland
2004-2022